| Orthocell Limited (OCC) ORDINARY FULLY PAID |
Health Care |
$183 |
Remplir Launches in Hong Kong with First Surgical Case
|
3 Nov 2025 9:12AM |
$1.165 |
$0.670 |
fallen by
42.49%
|
|
OCC - Price-sensitive ASX Announcement
Full Release
Key Points
- Successful completion of first Remplirâ„¢ surgical case in Hong Kong.
- Launch at Hong Kong Orthopaedic Association's 45th Annual Congress.
- Appointment of MontsMed as exclusive distributor for Hong Kong.
- Hong Kong serves as a strategic entry point to Greater Bay Area.
- Initial surgeries in Singapore and USA; sales expected in Canada and Thailand.
- Orthocell well-funded with A$50 million and aims for revenue growth in FY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Panther Metals Ltd (PNT) ORDINARY FULLY PAID |
Materials |
$2 |
Non-Renounceable Rights Issue to Raise $817k
|
3 Nov 2025 9:12AM |
$0.011 |
$0.006 |
fallen by
42.86%
|
|
PNT - Price-sensitive ASX Announcement
Full Release
Key Points
- $817k non-renounceable rights issue
- 20% discount to the last closing price
- Funds for Laverton Gold Project exploration
- Shortfall facility available for additional shares
- Directors committed to $105,000
- Offer open in Australia, New Zealand, and UK
- Closing date is 21 November 2025
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ariadne Australia Limited (ARA) ORDINARY FULLY PAID |
Industrials |
$88 |
Update - Notification of buy-back - ARA
|
3 Nov 2025 9:11AM |
$0.500 |
$0.460 |
fallen by
8%
|
|
| Medallion Metals Limited (MM8) ORDINARY FULLY PAID |
Materials |
$408 |
RGP Advances Following Key Permitting Milestone
|
3 Nov 2025 9:11AM |
$0.455 |
$0.440 |
fallen by
3.30%
|
|
MM8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Ravensthorpe Gold Project (RGP) has advanced to the final stage of assessment under the Environment Protection and Biodiversity Conservation Act 1999 (EPBC Act).
- A determination on the proposed action is expected during December 2025, subject to no requests for additional information.
- Approval under the EPBC Act is crucial for Medallion Metals' sulphide production strategy.
- The project is being assessed on Preliminary Documentation with no public comments received during the 20-business day comment period.
- Further secondary approvals will be needed under State (WA) legislation.
- This announcement is authorized for release by the Board of Medallion Metals Limited.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Retail Food Group Limited (RFG) ORDINARY FULLY PAID |
Consumer Discretionary |
$63 |
Change in substantial holding
|
3 Nov 2025 9:10AM |
$1.470 |
$0.990 |
fallen by
32.65%
|
|
| Alma Metals Limited (ALM) CHESS DEPOSITARY INTERESTS 1:1 |
Energy |
$21 |
Briggs Copper Project - Expansion of Drilling Program
|
3 Nov 2025 9:09AM |
$0.008 |
$0.008 |
fallen by
0%
|
|
ALM - Price-sensitive ASX Announcement
Full Release
Key Points
- Alma Metals Limited reached a 51% joint venture interest in Briggs Copper Project in August 2024.
- Alma aims for 70% JV interest by spending $10 million by June 2031.
- Exploration involves drilling into granodiorite porphyry stocks with copper and molybdenum.
- Copper deposition is multi-stage, linked to different alterations and intrusions.
- Further drilling is planned to explore potential extensions.
- The geological settings indicate promising mineralization and exploration potential.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Eureka Group Holdings Limited (EGH) ORDINARY FULLY PAID |
Real Estate |
$348 |
Appointment of Joint Company Secretary
|
3 Nov 2025 9:09AM |
$0.530 |
$0.620 |
risen by
16.98%
|
|
| BKI Investment Company Limited (BKI) ORDINARY FULLY PAID |
Financials |
$1,433 |
BKI 31 October 2025 Weekly NTA
|
3 Nov 2025 9:09AM |
$1.800 |
$1.775 |
fallen by
1.39%
|
|
| Cash Converters International (CCV) ORDINARY FULLY PAID |
Financials |
$186 |
Notice under section 708A(5)(e) of the Corporations Act
|
3 Nov 2025 9:09AM |
$0.315 |
$0.260 |
fallen by
17.46%
|
|
| PM Capital Global Opportunities Fund Limited (PGF) ORDINARY FULLY PAID |
Financials |
$1,919 |
Net Tangible Asset Backing - 31 October 2025
|
3 Nov 2025 9:09AM |
$2.720 |
$3.150 |
risen by
15.81%
|
|
| Anteris Technologies Ltd (AVR) CHESS DEPOSITARY INTERESTS 1:1 |
Health Care |
$131 |
FDA Approves DurAVR THV Global Pivotal Trial
|
3 Nov 2025 9:08AM |
$7.070 |
$9.010 |
risen by
27.44%
|
|
AVR - Price-sensitive ASX Announcement
Full Release
Key Points
- FDA approved the PARADIGM Trial for DurAVR® THV.
- Trial aims to evaluate DurAVR® THV for severe calcific aortic stenosis.
- PARADIGM Trial involves 1000 patients across the US, Europe, and Canada.
- The trial compares DurAVR® THV with existing TAVR devices.
- It seeks to support FDA Premarket Approval and CE Mark.
- DurAVR® THV is a biomimetic valve for aortic stenosis.
- Anteris uses ADAPT® tissue technology in DurAVR® THV.
- The trial is a critical step in Anteris' global expansion strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orcoda Limited (ODA) ORDINARY FULLY PAID |
Information Technology |
$11 |
Change of Director's Interest Notice - Geoff Jamieson
|
3 Nov 2025 9:08AM |
$0.071 |
$0.059 |
fallen by
16.90%
|
|
| FireFly Metals Ltd (FFM) ORDINARY FULLY PAID |
Materials |
$1,226 |
Director Appointment/Resignation
|
3 Nov 2025 9:07AM |
$1.900 |
$1.405 |
fallen by
26.05%
|
|
| L1 Group Limited (L1G) ORDINARY FULLY PAID |
Financials |
$2,900 |
Appendix 3X - Julian Russell
|
3 Nov 2025 9:07AM |
$1.130 |
$1.130 |
fallen by
0%
|
|
| White Cliff Minerals Limited (WCN) ORDINARY FULLY PAID |
Materials |
$89 |
Strategic acquisition of Bornite Lake prospect at Rae
|
3 Nov 2025 9:07AM |
$0.020 |
$0.026 |
risen by
30%
|
|
WCN - Price-sensitive ASX Announcement
Full Release
Key Points
- Strategic acquisition of the Bornite Lake prospect at Rae.
- Consolidation of holdings along the Herb Dixon fault.
- Evidence of high-grade chalcocite-bornite mineralization.
- Historical copper and silver content reported.
- Plans to explore fault intersections for further mineralization.
- Acquisition enables a unified, province-scale strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Articore Group Limited (ATG) ORDINARY FULLY PAID |
Consumer Discretionary |
$114 |
Update - Notification of buy-back - ATG
|
3 Nov 2025 9:06AM |
$0.320 |
$0.390 |
risen by
21.88%
|
|
| Tivan Limited (TVN) ORDINARY FULLY PAID |
Materials |
$411 |
Tivan and Sumitomo agree MoU for Molyhil Project
|
3 Nov 2025 9:06AM |
$0.185 |
$0.175 |
fallen by
5.41%
|
|
TVN - Price-sensitive ASX Announcement
Full Release
Key Points
- Tivan Limited has signed a Memorandum of Understanding (MoU) with Sumitomo Corporation for the Molyhil Tungsten-Molybdenum Project in the Northern Territory.
- Sumitomo Corporation is a leading Japanese trading house, part of the Fortune Global 500.
- The MoU facilitates discussions on potential collaboration in development, funding, and operation of the Molyhil Project.
- This represents the third project collaboration between Tivan and Sumitomo Corporation.
- Tivan acquired the Molyhil Project in September 2025, which hosts a significant JORC Code (2012) Mineral Resource Estimate.
- The Molyhil Project is located approximately 220km north-east of Alice Springs.
- Tivan plans to develop a high-value critical minerals precinct in central Australia.
- The Molyhil Project, hosting tungsten and molybdenum, has strategic importance due to their critical mineral status.
- The MoU provides exclusivity to Sumitomo Corporation until 15 April 2026, subject to negotiation and execution of commercial agreements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Maronan Metals Limited (MMA) ORDINARY FULLY PAID |
Materials |
$132 |
Update - Proposed issue of securities - MMA
|
3 Nov 2025 9:06AM |
$0.335 |
$0.420 |
risen by
25.37%
|
|
| APA Group (APA) FULLY PAID UNITS STAPLED SECURITIES |
Utilities |
$14,968 |
Change of Director's Interest Notice - Adam Watson
|
3 Nov 2025 9:05AM |
$9.180 |
$11.230 |
risen by
22.33%
|
|
| Ironbark Balanced Income Limited (IBC) ORDINARY FULLY PAID |
Financials |
$43 |
Update - Notification of buy-back - IBC
|
3 Nov 2025 9:05AM |
$0.440 |
$0.430 |
fallen by
2.27%
|
|
| Dimensional Global Small Company Trust - Active ETF (DGSM) |
Financials |
$707 |
Product Disclosure Statement Announcement
|
3 Nov 2025 9:05AM |
$36.330 |
$38.690 |
risen by
6.50%
|
|
| Dimensional Australian Core Equity (Managed Fund) (DACE) |
Financials |
$6,991 |
Product Disclosure Statement Announcement
|
3 Nov 2025 9:05AM |
$18.670 |
$18.570 |
fallen by
0.54%
|
|
| Dimensional Global Core Eq Unhgd (Managed Fund) (DGCE) |
Financials |
$5,753 |
Product Disclosure Statement Announcement
|
3 Nov 2025 9:05AM |
$30.220 |
$32.590 |
risen by
7.84%
|
|
| Dimensional Global Core Eq Aud Hgd (Managed Fund) (DFGH) |
Financials |
$4,265 |
Product Disclosure Statement Announcement
|
3 Nov 2025 9:05AM |
$40.000 |
$43.990 |
risen by
9.98%
|
|
| Dimensional Australian Value Trust - Active ETF (DAVA) |
Financials |
$1,565 |
Product Disclosure Statement Announcement
|
3 Nov 2025 9:05AM |
$30.360 |
$31.460 |
risen by
3.62%
|
|